FDA Inspection 1152174 - Takeda Pharmaceuticals U.S.A. - September 01, 2021

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Takeda Pharmaceuticals U.S.A., with an inspection on September 1, 2021, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Takeda Pharmaceuticals U.S.A.
Inspection Date: September 1, 2021
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · 243add49-3771-4c66-a4c3-4e2af69c2f4f